BioSpace News Archive

Connecticut Governor Ned Lamont, New Haven Mayor Justin Elicker, and Josh Geballe, Managing Director of Yale Ventures, participated in the launch ceremony of the new BioMed X Institute on Tuesday, June 11, 2024.

QIAGEN announced the release of a new version of its clinical decision support software, QIAGEN Clinical Insight Interpret, that brings significant performance and scalability enhancements tailored for high-throughput, next-generation sequencing labs moving to larger test panels and higher test volumes.

Senseonics Holdings, Inc. announced plans to host a business update and analyst event during the American Diabetes Association’s 84th Scientific Sessions in Orlando, FL.

AlzeCure Pharma announced that a scientific article has been published on the clinical phase Ib results that support the continued development of the lead drug candidate Painless ACD440.

Sirnaomics Ltd., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced that the Group has published a major advancement of its novel Oligonucleotide-Chemodrug Conjugate agent.

SOPHiA GENETICS, a cloud-native healthcare technology company and a leader in data-driven medicine, announced that Kepler Uniklinikum, Austria’s second largest hospital, is live on SOPHiA GENETICS’ platform.

Providence Medical Technology, Inc., an innovator in solutions for spinal surgery, announces that the U.S. Food and Drug Administration has cleared the use of the CORUS™ Navigation Access System for use with the CORUS Spinal System during spinal surgery.

Jumpcode Genomics and Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., announced the companies have settled their patent dispute and have partnered to bring together their combined foundational IP in the field of targeted depletion of undesired transcripts such as ribosomal RNAs from NGS libraries using CRISPR-based technology.